NCT06369363View on ClinicalTrials.gov

Estrogen Deficiency on Cardiovascular Risk

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

November 30, 2027

Conditions
Postmenopausal SymptomsCardiovascular Diseases
Interventions
DRUG

Placebo

Subjects will be assigned to 1 week of transdermal placebo patch.

DRUG

Estradiol

Subjects will be assigned to 1 week of transdermal estradiol (0.05 mg/day) patch.

All Listed Sponsors
lead

Milton S. Hershey Medical Center

OTHER